A high hematocrit (HCT) level is strongly associated
with the risk
of cardiovascular disease. For early diagnosis of cardiovascular disease,
it is vital to regularly measure the HCT, which is typically achieved
by centrifuging a blood sample to measure the percentage of red blood
cells. However, the centrifugal modalities are usually bulky, expensive,
and require a stable electric input, which restrict the availability.
This research develops a semi-automatic and portable centrifugal device
for HCT measurement. This torque-actuated semi-automatic centrifuge,
which we call the tFuge, is inspired by a music box, allowing different
operators to generate the same rhythm. It is electricity-free and
can be controlled based on a constant torque mechanism. Repeatable
test results can be received from among different users regardless
of their age, sex, and activity. With the assistance of the Boycott
effect on the tFuge, we proved that the HCT level is in high linearity
to the length of the sedimentation of the blood cells in a tube (R
2 = 0.99, sample HCT range 10–60%). The
tFuge takes less than 4 min and requires no more than 10 μL
of blood that can be obtained by a less-invasive finger prick to complete
the testing procedure. Calibrated gradient numbers are printed onto
the rotation disc for instant HCT results that can be read by the
naked eye. We expect this proposed point-of-care testing device possesses
the potential to replace the microhematocrit centrifuge in the regions
with limited resources.